Anti-inflammatory drugs that leave you open to deadly viral infections

Drugs were designed to banish discomfort and disease.

But a new study has revealed that a class of common anti-inflammatory drugs may actually make people sicker. 

Researchers at the Norwegian University of Science and Technology (NTNU) have found that a group of medications known as Janus kinase (JAK) inhibitors may increase the body’s susceptibility to viral infections.

The medications work by blocking immune system proteins in the body that often lead to inflammation and pain. 

These medications are used to treat a range of medical conditions affecting millions worldwide, such as rheumatoid arthritis, eczema, alopecia, and certain bone cancers.

These are relatively recent drugs, with the first JAK inhibitor, marketed as Jakafi for cancer therapy, gaining FDA approval only in 2011.

However, there is now evidence suggesting these drugs – which are typically taken as pills – could help the flu, Covid-19 and other viruses infiltrate the body’s immune system, potentially leading to severe infection.

The scientists say this is because the drugs ‘suppress an important immune signaling pathway that helps protect healthy cells from viral attacks.’

Drugs are supposed to help banish discomfort and disease, but a new study has revealed that a class of anti-inflammatory drugs can actually make people sicker (stock image)

Drugs are supposed to help banish discomfort and disease, but a new study has revealed that a class of anti-inflammatory drugs can actually make people sicker (stock image)

The scientists found drugs in the class, such as baricitinib, which is sold under the brand name Olumiant for the treatment of alopecia – slow down the genes that respond to viruses.

‘These genes play a crucial role in the body’s response to viral infections,’ said Aleksandr Ianevski, an NTNU researcher and co-author of the new paper.

By stopping or slowing down this pathway, JAK inhibitors remove the body’s ‘antiviral shield’. 

This allows viruses to more easily gain a foothold in the body and spread.

The researchers used advanced techniques in a lab to look at how JAK inhibitors impact organs and how viruses attack the body once they have been exposed.  

They examined cells from the lungs, eyes and brain, as well as laboratory-created mini-organs.

Off the back of their findings Erlend Ravlo, a PhD research fellow at NTNU, said: ‘Although JAK inhibitors are effective in the treatment of inflammation, this shows that they can pose a hidden risk for patients who have latent or active viral infections.’

The findings suggest healthcare professionals should be cautious when prescribing JAK inhibitors, especially during viral outbreaks.

Common side effects of the medications include headaches, nausea, fatigue, diarrhea, acne, and elevated cholesterol.

Meanwhile, rarer but more serious side effects include severe infections like pneumonia or shingles, damage to the stomach or intestines, and changes in blood cell counts.

Dr Sarah Erickson, who specializes in treating hair loss, sounds the alarm about JAK inhibitors in one of her TikToks where she notes some of the 'harsh' side effects

Dr Sarah Erickson, who specializes in treating hair loss, sounds the alarm about JAK inhibitors in one of her TikToks where she notes some of the ‘harsh’ side effects

They are relatively new drugs, and the first JAK inhibitor, sold under the brand name Jakafi for cancer treatment, was only just approved by the FDA in 2011 (stock image)

They are relatively new drugs, and the first JAK inhibitor, sold under the brand name Jakafi for cancer treatment, was only just approved by the FDA in 2011 (stock image)

While the immunosuppressive effects of the drugs could be harmful, the researchers point out that it could be useful in controlled environments, such as in the development of vaccines or screening of antiviral drugs.

‘We recommend further studies to better understand how the drugs can be used optimally, especially during virus outbreaks or pandemics,’ says Ianevski. 

The researchers hope to increase awareness among doctors and researchers about the effects of these drugs to prevent patients from developing new illnesses.

This is especially important for vulnerable patients, such as the elderly or individuals with chronic illnesses or disabilities. 

The findings were published in the medical journal, NAR Molecular Medicine.

You May Also Like

Trump Says Nvidia CEO Jensen Huang Should Be Reinstated

President Donald Trump has backed the idea of returning former Nvidia chief…

Russell Brand’s Former Flatmate Describes His ‘Narcissistic’ Room

Russell Brand’s former flatmate has revisited the London bedroom where the comedian…

Man Killed, Woman Hurt in Double Stabbing Outside NYC Store

A man was killed and a woman injured in a double stabbing…

NYC Subway Shooter Who Accidentally Wounded Bystander Is Sentenced

A subway shooting on Manhattan’s Upper East Side ended with Steven Sylvester…

Inside Russell Brand’s Move to HMP Littlehey: He’s Won the Lottery

Just days into his new life as a convicted rapist, Russell Brand…

5-Year-Old Dies After Falling From Second-Floor Window at Los Angeles Home

A five-year-old child died Sunday after falling from an upstairs window at…

Independent Indi MP Helen Haines grateful after hospital discharge

Independent federal MP Helen Haines says she is “full of gratitude” as…

Elizabeth Holmes: Idealistic Theranos Visionary or Calculated Fraudster?

Critics have lavished extraordinary praise on the film, calling it “ingenious”, “stupefying”,…

Mexican Drug Lord Portrayed in Netflix’s Narcos Dies at 80

Miguel Ángel Félix Gallardo, the notorious Mexican drug lord whose ascent and…

Tobey Maguire Leads Stars at Leonardo DiCaprio’s 52nd Birthday

Tobey Maguire was among the notable guests at his close friend Leonardo…

Court Hears Accused Police Officer Faked Gun Return to Kill Ex-Lover

Accused killer Beau Lamarre-Condon spent Friday facing sustained cross-examination in the witness…

Puberty Blockers Get Regulatory Green Light Amid Debate

Australian authorities will recommend puberty blockers as a treatment option for some…